DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 065173
NDA 065173 describes PAROMOMYCIN SULFATE, which is a drug marketed by Heritage Pharms Inc and Sun Pharm Inds Inc and is included in two NDAs. It is available from four suppliers. Additional details are available on the PAROMOMYCIN SULFATE profile page.
The generic ingredient in PAROMOMYCIN SULFATE is paromomycin sulfate. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the paromomycin sulfate profile page.
The generic ingredient in PAROMOMYCIN SULFATE is paromomycin sulfate. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the paromomycin sulfate profile page.
Summary for 065173
| Tradename: | PAROMOMYCIN SULFATE |
| Applicant: | Heritage Pharms Inc |
| Ingredient: | paromomycin sulfate |
| Patents: | 0 |
| Therapeutic Class: | Antibacterials |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 065173
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PAROMOMYCIN SULFATE | paromomycin sulfate | CAPSULE;ORAL | 065173 | ANDA | Heritage Pharmaceuticals Inc. | 23155-038 | N | 23155-038-01 |
| PAROMOMYCIN SULFATE | paromomycin sulfate | CAPSULE;ORAL | 065173 | ANDA | Department of State Health Services, Pharmacy Branch | 55695-022 | N | 55695-022-00 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Dec 14, 2007 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
